Parkinson's disease (PD) is a neurodegenerative disorder that predominantly affects dopamine-producing neurons in the substantia nigra, a region of the brain. It is the second most common neurodegenerative disorder after Alzheimer's disease, impacting millions worldwide. This article aims to provide a comprehensive overview of PD for healthcare professionals.
The exact cause of PD is unknown, but it is thought to result from a complex interplay of genetic and environmental factors. The hallmark pathological feature is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to striatal dopamine deficiency. This results in motor symptoms such as bradykinesia, rigidity, and resting tremor.
PD typically presents in the sixth decade of life or later. The cardinal motor symptoms are resting tremor, bradykinesia, and rigidity. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders often precede the motor symptoms and can significantly impact quality of life.
There is no definitive diagnostic test for PD. Diagnosis is primarily clinical, based on history and neurological examination. Imaging, such as DaTscan, can support the diagnosis. Management of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. Non-pharmacological interventions, including physical therapy and exercise, also play a crucial role.
PD is a progressive disorder. The rate of progression varies widely among individuals. Factors associated with faster progression include older age at onset, presence of postural instability and gait difficulty, and cognitive impairment. Despite advances in treatment, PD remains a leading cause of disability.
Understanding the complexities of Parkinson's disease is crucial for healthcare professionals. As we continue to unravel the mysteries of this disorder, we can hope to improve diagnosis, management, and ultimately, patient outcomes. Continued research and education are key to achieving these goals.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation